TPCHRF - Round 6 - Pre-clinical assessment of poly-arginine R18 peptide as neuroprotective agent for perinatal hypoxic-ischaemic encephalopathy (HIE)

    StatusActive
    Effective start/end date1/07/1830/06/20

    Funding

    • WA Department of Health